Shanghai Henlius Biotech, Inc. (HKG: 2696)

Shanghai Henlius Biotech Revenue

Shanghai Henlius Biotech had revenue of 1.37B CNY in the quarter ending June 30, 2024, with 9.82% growth. This brings the company's revenue in the last twelve months to 5.64B, up 27.45% year-over-year. In the year 2023, Shanghai Henlius Biotech had annual revenue of 5.39B with 67.82% growth.

• Revenue (ttm): 5.64B CNY
• Revenue Growth: +27.45%
• P/S Ratio: 2.12
• Revenue / Employee: 1.55M CNY
• Employees: 3,637
• Market Cap: 12.85B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.39B	2.18B	67.82%
Dec 31, 2022	3.21B	1.53B	91.07%
Dec 31, 2021	1.68B	1.09B	186.34%
Dec 31, 2020	587.59M	496.66M	546.20%
Dec 31, 2019	90.93M	83.51M	1,125.29%